RO5212054 / Daiichi Sankyo  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RO5212054 / Daiichi Sankyo
NCT01143753: A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors

Completed
1
45
Europe, RoW
RO5212054, PLX3603
Hoffmann-La Roche
Neoplasms
06/12
05/17

Download Options